pindolol has been researched along with Pseudohypoparathyroidism in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heinsimer, JA | 1 |
| Davies, AO | 1 |
| Downs, RW | 1 |
| Levine, MA | 1 |
| Spiegel, AM | 1 |
| Drezner, MK | 1 |
| De Lean, A | 1 |
| Wreggett, KA | 1 |
| Caron, MG | 1 |
| Lefkowitz, RJ | 1 |
1 other study available for pindolol and Pseudohypoparathyroidism
| Article | Year |
|---|---|
Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.
Topics: Adenylyl Cyclases; Adolescent; Adult; Binding Sites; Child; Erythrocyte Membrane; Female; Humans; Io | 1984 |